The steroid measurements reagents market is projected to grow from USD 1,794.0 million in 2026 to USD 3,663.2 million by 2036, at a CAGR of 7.4%. Calibrators & sample prep reagents will dominate with a 21.0% market share, while endocrine disorder diagnosis will lead the applications segment with a 28.0% share.